These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 25674225

  • 21. Loss of heterozygosity for loci on chromosome arms 1p and 10q in oligodendroglial tumors: relationship to outcome and chemosensitivity.
    Thiessen B, Maguire JA, McNeil K, Huntsman D, Martin MA, Horsman D.
    J Neurooncol; 2003 Sep; 64(3):271-8. PubMed ID: 14558604
    [Abstract] [Full Text] [Related]

  • 22. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.
    Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN.
    J Natl Cancer Inst; 1998 Oct 07; 90(19):1473-9. PubMed ID: 9776413
    [Abstract] [Full Text] [Related]

  • 23. Loss of 1p, 19q, and 10q heterozygosity prospectively predicts prognosis of oligodendroglial tumors--towards individualized tumor treatment?
    Ramirez C, Bowman C, Maurage CA, Dubois F, Blond S, Porchet N, Escande F.
    Neuro Oncol; 2010 May 07; 12(5):490-9. PubMed ID: 20156805
    [Abstract] [Full Text] [Related]

  • 24. Allelic status of 1p and 19q in oligodendrogliomas and glioblastomas: multiplex ligation-dependent probe amplification versus loss of heterozygosity.
    Franco-Hernández C, Martínez-Glez V, de Campos JM, Isla A, Vaquero J, Gutiérrez M, Casartelli C, Rey JA.
    Cancer Genet Cytogenet; 2009 Apr 15; 190(2):93-6. PubMed ID: 19380026
    [Abstract] [Full Text] [Related]

  • 25. Prognostic variables in oligodendroglial tumors: a single-institution study of 95 cases.
    Scheie D, Meling TR, Cvancarova M, Skullerud K, Mørk S, Lote K, Eide TJ, Helseth E, Beiske K.
    Neuro Oncol; 2011 Nov 15; 13(11):1225-33. PubMed ID: 21856683
    [Abstract] [Full Text] [Related]

  • 26. Fluorescence in situ hybridization (FISH) on touch preparations: a reliable method for detecting loss of heterozygosity at 1p and 19q in oligodendroglial tumors.
    Scheie D, Andresen PA, Cvancarova M, Bø AS, Helseth E, Skullerud K, Beiske K.
    Am J Surg Pathol; 2006 Jul 15; 30(7):828-37. PubMed ID: 16819324
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Polysomy for chromosomes 1 and 19 predicts earlier recurrence in anaplastic oligodendrogliomas with concurrent 1p/19q loss.
    Snuderl M, Eichler AF, Ligon KL, Vu QU, Silver M, Betensky RA, Ligon AH, Wen PY, Louis DN, Iafrate AJ.
    Clin Cancer Res; 2009 Oct 15; 15(20):6430-7. PubMed ID: 19808867
    [Abstract] [Full Text] [Related]

  • 31. Progressive low-grade oligodendrogliomas: response to temozolomide and correlation between genetic profile and O6-methylguanine DNA methyltransferase protein expression.
    Levin N, Lavon I, Zelikovitsh B, Fuchs D, Bokstein F, Fellig Y, Siegal T.
    Cancer; 2006 Apr 15; 106(8):1759-65. PubMed ID: 16541434
    [Abstract] [Full Text] [Related]

  • 32. Prognosis of oligodendroglial tumor with ring enhancement showing central necrotic portion.
    Choi KY, Jung TY, Jung S, Kim YH, Moon KS, Kim IY, Kang SS, Lee KH.
    J Neurooncol; 2011 May 15; 103(1):103-10. PubMed ID: 20737192
    [Abstract] [Full Text] [Related]

  • 33. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.
    Smith JS, Perry A, Borell TJ, Lee HK, O'Fallon J, Hosek SM, Kimmel D, Yates A, Burger PC, Scheithauer BW, Jenkins RB.
    J Clin Oncol; 2000 Feb 15; 18(3):636-45. PubMed ID: 10653879
    [Abstract] [Full Text] [Related]

  • 34. Chromosomal alterations in oligodendroglial tumours over multiple surgeries: is tumour progression associated with change in 1p/19q status?
    Campbell BA, Horsman DE, Maguire J, Young S, Curman D, Ma R, Thiessen B.
    J Neurooncol; 2008 Aug 15; 89(1):37-45. PubMed ID: 18458822
    [Abstract] [Full Text] [Related]

  • 35. Characterization of the 1p/19q chromosomal loss in oligodendrogliomas using comparative genomic hybridization arrays (CGHa).
    Cowell JK, Barnett GH, Nowak NJ.
    J Neuropathol Exp Neurol; 2004 Feb 15; 63(2):151-8. PubMed ID: 14989601
    [Abstract] [Full Text] [Related]

  • 36. Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization.
    Bigner SH, Matthews MR, Rasheed BK, Wiltshire RN, Friedman HS, Friedman AH, Stenzel TT, Dawes DM, McLendon RE, Bigner DD.
    Am J Pathol; 1999 Aug 15; 155(2):375-86. PubMed ID: 10433931
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Heterozygosity status of 1p and 19q and its correlation with p53 protein expression and EGFR amplification in patients with astrocytic tumors: novel series from India.
    Jha P, Agarwal S, Pathak P, Srivastava A, Suri V, Sharma MC, Chosdol K, Srivastava T, Gupta D, Gupta A, Suri A, Sarkar C.
    Cancer Genet Cytogenet; 2010 Apr 15; 198(2):126-34. PubMed ID: 20362227
    [Abstract] [Full Text] [Related]

  • 39. Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas.
    Fallon KB, Palmer CA, Roth KA, Nabors LB, Wang W, Carpenter M, Banerjee R, Forsyth P, Rich K, Perry A.
    J Neuropathol Exp Neurol; 2004 Apr 15; 63(4):314-22. PubMed ID: 15099021
    [Abstract] [Full Text] [Related]

  • 40. Loss of heterozygosity at 1p-19q induces a global change in oligodendroglial tumor gene expression.
    Ferrer-Luna R, Mata M, Núñez L, Calvar J, Dasí F, Arias E, Piquer J, Cerdá-Nicolás M, Taratuto AL, Sevlever G, Celda B, Martinetto H.
    J Neurooncol; 2009 Dec 15; 95(3):343-354. PubMed ID: 19597701
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.